Anti-malarial drugs for diabetes cure
Preliminary research has suggested that use of the anti-malarial drug hydroxychloroquine may help reduce the risk of patients with rheumatoid arthritis developing diabetes. Type 2 diabetes mellitus affects nearly 8 percent of US adults, and its prevalence has been increasing. Antimalarials such as hydroxychloroquine, a long-standing safe and inexpensive treatment for an autoimmune disease such [...]